Search Results

FDA Issues Second Complete Response Letter for AbbVie's Parkinson's Therapy.

Subjects: *PHARMACEUTICAL industry; PARKINSON'S disease treatment; PATIENT safetyUNITED StatesUNITED States. Food & Drug Administration

• Source: Formulary Watch. 6/25/2024, p1-1. 1p.

Record details

Narrative Medicine Interventions for Advance Care Planning in Parkinson's Disease.

• Authors : Jiao, Jocelyn^1,2 ; Brumbach, Barbara H.³; Lobb, Brenna²

Subjects: *PARKINSON'S disease treatment; *INTELLECT; *SELF-efficacy

• Source: Journal of Palliative Medicine. Aug2024, Vol. 27 Issue 8, p984-985. 2p.

Record details

The efficacy and safety of coenzyme Q10 in Parkinson's disease: a meta-analysis of randomized controlled trials.

• Authors : Zhu, Zhen-Guo; Sun, Miao-Xuan; Zhang, Wan-Li

Subjects: PARKINSON'S disease treatment; THERAPEUTIC use of ubiquinones; RANDOMIZED controlled trials

• Source: Neurological Sciences. Feb2017, Vol. 38 Issue 2, p215-224. 10p.

Record details

Young blood tested on Parkinson's.

• Authors : Klein, Alice

Subjects: BLOOD transfusion; PARKINSON'S disease treatment; YOUNG adults

• Source: New Scientist. 1/5/2019, Vol. 241 Issue 3211, p6-6. 1p. 1 Color Photograph.

Record details

THE REGENERATING BRAIN.

• Authors : DENWORTH, LYDIA

Subjects: STEM cell treatment; PARKINSON'S disease treatment; DOPAMINE

• Source: Scientific American Mind. May/Jun2014, Vol. 25 Issue 3, p59-65. 7p. 1 Chart.

Record details

Promising trial results for Teva's Parkinson's drug.

Subjects: *PHARMACEUTICAL industry; PARKINSON'S disease treatment; EXTRAPYRAMIDAL disordersTEVA Neuroscience Inc.

• Source: PharmaWatch: CNS. October 2004, Vol. 3 Issue 10, p9-10. 2p.

Record details

Parkinson's Disease Update.

Subjects: *PRODUCT recall; PARKINSON'S disease treatment; CLINICAL trialsUNITED StatesSOLVAY Pharmaceuticals Inc. SOLVAY Pharmaceuticals Inc. SOLVAY Pharmaceuticals Inc. 003309358 ; UCB Pharma Inc. UCB Pharma Inc. UCB Pharma Inc. 037480084 ; NEUROLOGIX Inc.

• Source: PharmaWatch: CNS. May2008, Vol. 7 Issue 5, p5-6. 2p.

Record details

Parkinson's Update.

Subjects: PARKINSON'S disease treatment; CLINICAL trials; CLINICAL drug trialsCEREGENE Inc. ; DEPOMED Inc. 937562890 DEPOMED Inc. DEPOMED Inc. 937562890 937562890 DEPOMED Inc. 937562890 DEPO

• Source: PharmaWatch: CNS. Mar2011, Vol. 10 Issue 3, p8-9. 2p.

Record details

Parkinson's Disease Update.

Subjects: PARKINSON'S disease treatment; CLINICAL trials; NEUROLOGICAL disordersACADIA Pharmaceuticals Inc. ACADIA Pharmaceuticals Inc. ACADIA Pharmaceuticals Inc. ACAD; LUNDBECK Inc. USA ; TEVA Pharmaceutical Industries Ltd.

• Source: PharmaWatch: CNS. August 2005, Vol. 4 Issue 8, p7-9. 3p.

Record details

Drug reverses Parkinson's.

• Authors : Hamzelou, Jessica

Subjects: NILOTINIB; PARKINSON'S disease treatment; CLINICAL trials

• Source: New Scientist. 10/24/2015, Vol. 228 Issue 3044, p1-1. 1p.

Record details